XORTX Therapeutics Inc. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Accounts payable and accrued liabilities

Accounts payable and accrued liabilities

12 Months Ended

Dec. 31, 2023

Accounts payable and accrued liabilities.

Accounts payable and accrued liabilities

10.Accounts payable and accrued liabilities


		December 31,		December 31,		January 1,
		2023		2022		2022
		$		$		$
Trade payables		195,814		1,293,807		323,961
Accrued liabilities		87,614		151,406		228,987
Total		283,428		1,445,213		552,948